Company Calmare Therapeutics Inc OTC Bulletin Board
Equities
CTTC
US2045121074
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
2020 | Calmare Therapeutics Incorporated Wins $2.5 Million Federal Supply Schedule Contract | CI |
2019 | Calmare Therapeutics Incorporated Announces Board Changes | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 26/09/13 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 30/09/07 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 26/09/13 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 05/06/11 |
Santanu Das
BRD | Director/Board Member | - | 11/07/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 38,997,971 | 38,997,971 ( 100.00 %) | 0 | 99.99 % |
Stock B | 0 | 2,427 | 0 | 0 |
Company contact information
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.6B |
- Stock Market
- Equities
- CTTC Stock
- CTTC Stock
- Company Calmare Therapeutics Inc